Badger Meter stock hits 52-week low at 120.41 USD

Badger Meter shares are down nearly 24% over the past year to $120.41, well below the $256.08 52-week high, despite commentary that the stock may be undervalued and that the company has raised its dividend for 33 straight years. The latest quarter missed estimates with EPS of $1.14 versus $1.16 expected and revenue of $220.7 million versus $231.98 million forecast. Offsetting that weakness, the company lifted buyback authorization to $150 million and announced a $100 million acquisition of UK-based UDlive Limited to expand sewer monitoring capabilities.

Analysis

BMI looks more like a quality compounder in a temporary de-rating than a broken story. The core issue is that investors are punishing any earnings miss plus anything tied to municipal/industrial capex, but the business still has unusually high recurring content, a long dividend record, and enough buyback capacity to cushion downside if growth normalizes. The market is effectively pricing in a multi-quarter stagnation scenario; that seems aggressive unless the recent revenue miss proves to be the start of a broader demand reset.

The more important second-order effect is that this is a classic “execution premium” stock: when growth names lose momentum, the multiple compresses faster than fundamentals, and then repurchases become a larger per-share earnings lever than usual. The new acquisition can be viewed as a small but strategic adjacency expansion into monitoring/software-like functionality, which may matter more to long-term valuation than near-term EPS. If integration is smooth, the market may eventually reward the company for moving further up the value stack rather than just selling metering hardware.

The contrarian risk is that consensus is likely underestimating how long it can take for water-infrastructure demand to re-accelerate; this could remain dead money for 2-4 quarters even if the business is fine structurally. On the flip side, the stock has likely already priced in a lot of bad news: if the next print merely stabilizes margins and confirms backlog resilience, the multiple can re-rate quickly because sentiment is so depressed. The key catalyst is not macro or geopolitics—it is whether management can restore confidence in organic growth and show that capital returns are being used from a position of strength rather than defense.

Key Decisions for Investors

• Initiate a tactical long BMI position on weakness, with a 3-6 month horizon and a stop tied to a fresh breakdown in revenue guidance; risk/reward is attractive if the stock mean-reverts to even a mid-teens forward multiple from depressed sentiment levels.
• Use a call spread in BMI rather than outright stock for the next earnings cycle; the thesis is that a stable print plus buyback support can re-rate shares 15-20% without requiring a full growth acceleration.
• Pair long BMI / short a higher-multiple industrial or water-infrastructure peer with weaker capital return support; the goal is to isolate valuation normalization against slower-growth exposure.
• If you already own BMI, hold through the next quarter but do not add until management proves the acquisition is accretive to monitoring-related growth; the downside case is not collapse, but prolonged multiple compression.
• Set a catalyst watch for the next two earnings reports: if organic growth and margin trends stabilize, increase exposure; if not, rotate capital into names with clearer cyclical upside and less execution risk.